Michael Morehead, MD
Neurology · Parkersburg, WVNPI 1245232727
Payments from drug & device makers
Across 12 payments — averaging $34.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$234
- Resmed Corp$100
- Apria Healthcare LLC$20
- AbbVie$17
- Catalyst Pharmaceuticals, Inc.$17
- Abbott$15
- plus $11 from 1 others
What the payments were for
- Food & beverage$15136%
- Education$26264%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $234 |
| Resmed Corp | 3 | $100 |
| Apria Healthcare LLC | 1 | $20 |
| AbbVie | 1 | $17 |
| Catalyst Pharmaceuticals, Inc. | 1 | $17 |
| Abbott | 1 | $15 |
| Amgen | 1 | $11 |
How this compares
$413 in reported general payments places this provider in the 35th percentile of 93 neurology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VumerityDiroximel Fumarate | 20 | $173,933 |
| TecfideraDimethyl Fumarate | 15 | $139,489 |
| CopaxoneGlatiramer Acetate | 20 | $114,633 |
| Kesimpta PenOfatumumab | 12 | $104,827 |
| Dalfampridine ErDalfampridine | 32 | $10,607 |
| DilantinPhenytoin Sodium Extended | 27 | $5,859 |
| Levetiracetam | 183 | $5,771 |
| Carbidopa | 14 | $4,568 |
| Rasagiline Mesylate | 32 | $4,048 |
| Modafinil | 71 | $2,833 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 121 | $2,643 |
| Divalproex Sodium | 61 | $2,227 |
| Divalproex Sodium ErDivalproex Sodium | 27 | $2,127 |
| Gabapentin | 146 | $1,970 |
| Oxcarbazepine | 59 | $1,890 |
Paid to pharmacies, not to this prescriber.
Other neurology in Parkersburg
- Barry VaughtCrab Orchard$3M
- Melanie WardMorgantown$1.4M
- Paul FergusonHuntington$754K
- Umer NajibMorgantown$477K
- Cheryl SmithMorgantown$394K
- Lauren SeebergerCharleston$288K
- Ann MurrayMorgantown$266K
- Shumaila SultanMorgantown$134K
- Eric SeachristMorgantown$95K
- Muhammed Nasher-AlneamCharleston$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.